Navigation Links
Blind humans lacking rods and cones retain normal responses to non-visual effects of light
Date:12/13/2007

In addition to allowing us to see, the mammalian eye also detects light for a number of non-visual phenomena. A prime example of this is the timing of the sleep/wake cycle, which is synchronized by the effects of light on the circadian pacemaker in the hypothalamus.

In a study published online on December 13th in Current Biology, researchers have identified two totally blind humans whose non-visual responses to light remain intact, suggesting that visual and non-visual responses to light are functionally distinct. Indeed, this separation was suggested by earlier studies in mice that demonstrated that circadian rhythms and other non-visual responses remain sensitive to light in the absence of rods and cones, the two photoreceptor types that are responsible for vision.

It turns out that mammals have an additional light-sensitive photoreceptor in the retinal ganglion cell layer (pRGCs) that is directly sensitive to light and is primarily responsible for mediating these responses. These cells are most sensitive to short-wavelength light with a peak sensitivity at ~480 nm, in the visible blue light range. While these studies and others in sighted subjects suggested that this non-rod, non-cone photoreceptor might play an important role in human photoreception, this had yet to demonstrated unequivocally until now.

To address whether the cells identified in rodents and primates also exist in humans, Zaidi and colleagues first had to find patients who lacked functional rods and cones, but retained pRGCsa formidable task, given that fewer than 5% of totally blind people are thought to retain this response.

This group of researchers was able to identify two such rare patients, allowing them to perform a series of complementary experiments to address whether non-visual responses are possible in the absence of rods and cones and to determine the most effective wavelength, or color, of light that induced a response. In the first patient
'/>"/>

Contact: Cathleen Genova
cgenova@cell.com
617-397-2802
Cell Press
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Can brain-injured, partially-blind stroke patients regain some of their lost vision?
2. New discovery may improve treatment of one of the worlds leading causes of blindness
3. Verizon Awards $1.5 Million Grant to Expand American Foundation for the Blinds Web Site for Seniors With Age-Related Vision Loss
4. Diabetes: A Top Cause of Blindness Among Adults
5. Blinded by the Light? Vision Problems and Visual Discomfort Make Driving in the Dark Difficult, Uncomfortable for Most Americans
6. Survey Confirms Americans Have a True Blind Spot Regarding Their Eye Health - and the Real Danger of UV Rays
7. STEP HIV vaccine study to be unblinded
8. Gene therapy safety trial for childhood blindness under way
9. National Federation of the Blind to Award $100,000
10. Investigational Agent Targeting Metabotropic Glutamate 2/3 Receptors Demonstrates Antipsychotic Activity in Humans, Study in Nature Medicine Finds
11. Toddler Study Proves Humans Outsmart Apes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/14/2014)... treat children with uncomplicated acute appendicitis is a reasonable ... fewer missed school days, according to a pilot study. ... Hospital and published online April 12 in the ... the first prospective study on nonoperative management of acute ... , Researchers enrolled 77 patients age 7 to 17 ...
(Date:4/14/2014)... 2014, Perth, Australia. Drug discovery company Proteomics International ... of a companion diagnostic (CDx) test with the ... The research team authenticated the panel of biomarkers ... samples. Seven biomarkers were validated at high stringency ... The mass spectrometry data was then cross-validated using ...
(Date:4/14/2014)... 2014) When it comes to the cost and ... Patients get the best care when they are treated ... extensive experience in their current job, according to a ... and Columbia Business School. The study was published in ... Applied Economics . , The review of more ...
(Date:4/13/2014)... STANFORD, Calif. A low-cost empowerment program for ... and sexual harassment of these girls, who live ... and are frequently attacked, a large new study ... Stanford University School of Medicine, Lucile Packard Children,s ... No Worldwide, validated the program,s effectiveness in combating ...
(Date:4/11/2014)... the processes that control brain cell production could pave ... brain-related disorders. , Scientists have gained new understanding of ... how and when nerve and brain cells are formed ... and keeps it healthy. Their findings could help explain ... which is a fundamental characteristic of many diseases including ...
Breaking Medicine News(10 mins):Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3Health News:Longer nurse tenure on hospital units leads to higher quality care 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 2Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 3Health News:Empowerment program greatly decreases incidence of rape, Stanford/Packard-led study finds 4
... ANGELES, Sept. 30 Actresses and mother-daughter pair Blythe Danner ... Entertainment Industry Foundation (EIF) public service announcement that celebrates the ... of PSAs that all major broadcast networks - ABC, CBS, FOX ... EIF,s iParticipate national initiative to promote service ...
... 30 According to a new,market research report, ,Neurostimulation ... for,neurostimulation products is expected to be worth $3.6 billion ... driven by the multiple treatment,applications of neurostimulation products, and ... Browse 48 market data tables and ...
... Sept. 30 On Tuesday, September 22, 2009, ... largest co-payment assistance organizations, hosted a panel discussion to ... underinsured and the related challenges of reducing financial barriers ... ) , Held at the National Press Club ...
... , SUNNYVALE, Calif., Sept. 30 Palo Alto Networks(TM), the ... selected to present at the Computer Forensics Show 2009, taking ... Julie Starr, a distinguished engineer at Palo Alto Networks, will ... and Control" in the IT Security Track on Oct. 6. ...
... Orexigen® Therapeutics, Inc. (Nasdaq: OREX ) today ... (bupropion SR/zonisamide SR), the Company,s second late stage investigational ... primary efficacy endpoint by demonstrating statistically significantly greater weight ... placebo. The Company plans to meet with the ...
... CITY, Calif., Sept. 30 Genomic Health, Inc. ... Health,s Chief Operating Officer and Chief Financial Officer, will present ... City, on Tuesday, October 6 at 9:30 a.m. ET. ... the presentation, visit the Investor Relations section of Genomic Health,s ...
Cached Medicine News:Health News:Blythe Danner and Gwyneth Paltrow Ask Americans to Volunteer for Healthier Life in New Public Service Announcement 2Health News:Blythe Danner and Gwyneth Paltrow Ask Americans to Volunteer for Healthier Life in New Public Service Announcement 3Health News:MarketsandMarkets: Global Neurostimulation Market Worth US$10.2 Billion by 2014 2Health News:MarketsandMarkets: Global Neurostimulation Market Worth US$10.2 Billion by 2014 3Health News:HealthWell Foundation(R) Gathers Leading Health Care Stakeholders to Discuss Crisis of the Underinsured 2Health News:HealthWell Foundation(R) Gathers Leading Health Care Stakeholders to Discuss Crisis of the Underinsured 3Health News:Palo Alto Networks to Present at the Computer Forensics Show 2009 2Health News:Orexigen(R) Therapeutics Phase 2b Trial for Empatic(TM) Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus Comparators in Obese Patients 2Health News:Orexigen(R) Therapeutics Phase 2b Trial for Empatic(TM) Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus Comparators in Obese Patients 3Health News:Orexigen(R) Therapeutics Phase 2b Trial for Empatic(TM) Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus Comparators in Obese Patients 4Health News:Orexigen(R) Therapeutics Phase 2b Trial for Empatic(TM) Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus Comparators in Obese Patients 5Health News:Orexigen(R) Therapeutics Phase 2b Trial for Empatic(TM) Meets Primary Efficacy Endpoint Demonstrating Significantly Greater Weight Loss Versus Comparators in Obese Patients 6
(Date:1/15/2014)... NEW YORK , January 15, 2014 ... subsidiary, BreedIT Ltd., the exclusive worldwide distributor of highly ... announced that on January 7, 2014, the Company,s board ... Ben-Zion Weiner as its new member of ... Weiner held executive positions with Teva Pharmaceutical Industries Ltd ...
(Date:1/15/2014)... -- MultiCell Technologies, Inc. (OTC Bulletin Board: ... concerning composition of matter, biological targets, mechanism of action, ... This patent application describes a novel ... (VSRNAs) which interfere with the basic homeostatic cellular processes ... than 10 bps, yet are surprisingly capable in their ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 /PRNewswire/ ... research report is available in its catalogue: ... & Forecast – Worldwide Analysis ... Pump Market Analysis ... the market as insulin delivery systems especially ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
... Medtronic has been a key participant ... for more than a decade. Previous Medtronic ... for concentrated platelets, as well as to ... for producing platelet-rich plasma (PRP) for a ...
This unique hemostatic seal provides a simple option for beating heart CABG anastomoses, allowing you to use your own hand-suturing technique without the release of cerebral emboli associated with th...
... Biliary Self-Expanding Stent System combines low-profile, high radial ... .018" guide wire compatible stent system provides 6F ... diameters (5.0 - 10.0 mm). Now, with longer ... in five stent lengths (28, 38, 56, 80 ...
... Supreme and Response catheters comprise ... catheters available for electrophysiology procedures. Their ... provide for superior torque response with ... multiple curves and French sizes, Supreme ...
Medicine Products: